These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32643512)

  • 1. Thinking more about therapy with convalescent plasma for COVID-19 patients.
    Han G; Zhou YH
    Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibodies, epicenter of SARS-CoV-2 immunology.
    Pecetta S; Pizza M; Sala C; Andreano E; Pileri P; Troisi M; Pantano E; Manganaro N; Rappuoli R
    Cell Death Differ; 2021 Feb; 28(2):821-824. PubMed ID: 33500559
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of COVID-19 Virus Infection by Convalescent Plasma.
    Cheraghali AM; Abolghasemi H; Eshghi P
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):3-6. PubMed ID: 32534509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain.
    Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S
    Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African Experience.
    Glatt TN; Hilton C; Nyoni C; Swarts A; Swanevelder R; Cowley J; Mmenu C; Moyo-Gwete T; Moore PL; Kutama M; Jaza J; Phayane I; Brits T; Koekemoer J; Jentsch U; Nelson D; van den Berg K; Vermeulen M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convalescent plasma for pediatric patients with SARS-CoV-2-associated acute respiratory distress syndrome.
    Diorio C; Anderson EM; McNerney KO; Goodwin EC; Chase JC; Bolton MJ; Arevalo CP; Weirick ME; Gouma S; Vella LA; Henrickson SE; Chiotos K; Fitzgerald JC; Kilbaugh TJ; John ARO; Blatz AM; Lambert MP; Sullivan KE; Tartaglione MR; Zambrano D; Martin M; Lee JH; Young P; Friedman D; Sesok-Pizzini DA; Hensley SE; Behrens EM; Bassiri H; Teachey DT
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28693. PubMed ID: 32885904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives for immune plasma treatment of COVID-19.
    Sayinalp B; Çinar OE; Haznedaroğlu İC
    Turk J Med Sci; 2021 Feb; 51(1):1-9. PubMed ID: 32718128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges of Convalescent Plasma Therapy on COVID-19.
    Zhao Q; He Y
    J Clin Virol; 2020 Jun; 127():104358. PubMed ID: 32305026
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutralizing monoclonal antibodies for treatment of COVID-19.
    Taylor PC; Adams AC; Hufford MM; de la Torre I; Winthrop K; Gottlieb RL
    Nat Rev Immunol; 2021 Jun; 21(6):382-393. PubMed ID: 33875867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case Report: Effects of Anti-SARS-CoV-2 Convalescent Antibodies Obtained With Double Filtration Plasmapheresis.
    Curtò D; Tomatis F; Gastoldi S; Galbusera M; Noris M; Raimondi F; Lorini FL; Falanga A; Marchetti M; Remuzzi G; Ruggenenti P
    Front Immunol; 2021; 12():711915. PubMed ID: 34276706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of convalescent plasma according to blood groups in COVID-19 patients.
    Hacibekiroğlu T; Kalpakçı Y; Genç AC; Hacibekiroğlu İ; Sunu C; Saricaoğlu A; Tomak Y; Karabay O; Köroğlu M
    Turk J Med Sci; 2021 Feb; 51(1):45-48. PubMed ID: 32950044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy.
    Focosi D; Franchini M; Casadevall A
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?
    Rnjak D; Ravlić S; Šola AM; Halassy B; Šemnički J; Šuperba M; Hećimović A; Kurolt IC; Kurtović T; Mačak Šafranko Ž; Polančec D; Bendelja K; Mušlin T; Jukić I; Vuk T; Zenić L; Artuković M
    Transfus Clin Biol; 2021 Aug; 28(3):264-270. PubMed ID: 33901641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of convalescent plasma and hyperimmune immunoglobulins against SARS-CoV-2 BQ.1, BQ.1.1, and XBB variants.
    Bellusci L; Golding H; Khurana S
    J Clin Invest; 2023 Apr; 133(8):. PubMed ID: 36821375
    [No Abstract]   [Full Text] [Related]  

  • 15. Convalescent plasma therapy for COVID-19: a tried-and-true old strategy?
    Xi Y
    Signal Transduct Target Ther; 2020 Sep; 5(1):203. PubMed ID: 32934211
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.
    Casadevall A; Henderson JP; Joyner MJ; Pirofski LA
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33621214
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between ABO blood group and neutralizing anti-SARS-CoV-2 antibody titers in convalescent plasma donations.
    Franchini M; Mengoli C; Ballotari A; Glingani C
    Transfus Clin Biol; 2022 May; 29(2):186-187. PubMed ID: 34690072
    [No Abstract]   [Full Text] [Related]  

  • 18. Locally harvested Covid-19 convalescent plasma could probably help combat the geographically determined SARS-CoV-2 viral variants.
    Raturi M; Kusum A; Kala M; Mittal G; Sharma A; Bansal N
    Transfus Clin Biol; 2021 Aug; 28(3):300-302. PubMed ID: 33971318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma.
    Donato ML; Park S; Baker M; Korngold R; Morawski A; Geng X; Tan M; Ip A; Goldberg S; Rowley S; Chow K; Brown E; Zenreich J; McKiernan P; Buttner K; Ullrich A; Long L; Feinman R; Ricourt A; Kemp M; Vendivil M; Suh H; Balani B; Cicogna C; Sebti R; Al-Khan A; Sperber S; Desai S; Fanning S; Arad D; Go R; Tam E; Rose K; Sadikot S; Siegel D; Gutierrez M; Feldman T; Goy A; Pecora A; Biran N; Leslie L; Gillio A; Timmapuri S; Boonstra M; Singer S; Kaur S; Richards E; Perlin DS
    JCI Insight; 2021 Mar; 6(6):. PubMed ID: 33571168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concentrated antibody from convalescent plasma balanced the dysfunctional immune responses in patients with critical COVID-19.
    Liao M; Liao X; Yuan J; Zhou B; Liu Y; Jiang X; Zhang Z; Guo C; Zhang Y; Zhang S; Liu L; Zhang Z
    Clin Transl Med; 2021 Nov; 11(11):e571. PubMed ID: 34841732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.